ClinicalTrials.Veeva

Menu

Quality of Life After Radiofrequency Ablation of Pancreatic Cancer

B

Brno University Hospital

Status

Completed

Conditions

Pancreatic Cancer

Treatments

Procedure: Radiofrequency ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT02637596
NT 14579-3

Details and patient eligibility

About

A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • histologically proved locally advanced or metastatic pancreatic cancer. Patients with histologically proved resectable pancreatic cancer with low Karnofsky index.

informed consent

Exclusion criteria

  • cystic tumor

age under 18

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

RFA group
Experimental group
Description:
Twenty-fourth consecutive patients with histologically proved pancreatic cancer \[stage IIb (n=4), III (n=15), IV (n=5) \]underwent intraoperative RFA of primary tumor.
Treatment:
Procedure: Radiofrequency ablation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems